IP Library › Assignment 028275/0357
Patent Assignment
Reel/Frame 028275/0357

Security Agreement

Recorded: 2012-05-25 Pages: 10
Assignors
STELLAR PHARMACEUTICALS INC.
Executed: 2012-05-11
TRIBUTE PHARMA CANADA INC.
Executed: 2012-05-11
Assignee
MIDCAP FUNDING III, LLC, AS AGENT
7255 WOODMONT AVENUE, SUITE 200, BETHESDA, MARYLAND, 20814
Covered Properties (4)
Treatment of Cystitis Like Systoms with Chondroitin Sulfate Following Administration of a Challenge Solution
Patent: 6,083,933 →
Application: 09/294,019 →
Cystitis Treatment with High Dose Chondroitin Sulfate
Patent: 7,772,210 →
Application: 10/546,511 →
Publication: US 2006/0194757
Cystitis Treatment with High Dose Chondroitin Sulfate
Patent: 8,084,441 →
Application: 12/804,478 →
Publication: US 2010/0292182
Cystitis Treatment with High Dose Chondroitin Sulfate
Patent: 8,334,276 →
Application: 13/373,226 →
Publication: US 2012/0058969
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Jul 21, 2010
From: STELLAR INTERNATIONAL INC.
To: STELLAR PHARMACEUTICALS INC.
Reel/Frame 024819/0712 →
Assignment of Assignor's Interest Nov 8, 2011
From: STELLAR INTERNATIONAL INC.
To: STELLAR PHARMACEUTICALS INC.
Reel/Frame 027331/0327 →
Assignment of Assignor's Interest Nov 8, 2011
From: RIEHL, PETER R.; HAHN, SUNGTACK SAMUEL
To: STELLAR INTERNATIONAL INC.
Reel/Frame 027331/0325 →
Merger Feb 21, 2013
From: STELLAR PHARMACEUTICALS INC.
To: TRIBUTE PHARMACEUTICALS CANADA INC.
Reel/Frame 029849/0376 →
Confirmation of Intellectual Property Security Agreement Recorded at Reel 28275, Frame 0357 Mar 20, 2013
From: TRIBUTE PHARMACEUTICALS CANADA INC.
To: MIDCAP FUNDING III, LLC, AS AGENT
Reel/Frame 030049/0126 →
Security Agreement Aug 8, 2013
From: TRIBUTE PHARACEUTICALS CANADA LLC
To: SWK FUNDING LLC
Reel/Frame 030988/0171 →
Release of Security Interest Aug 27, 2013
From: MIDCAP FUNDING III, LLC
To: TRIBUTE PHARMACEUTICALS CANADA INC.
Reel/Frame 031093/0486 →
Release of Security Interest Feb 5, 2016
From: SWK FUNDING LLC
To: TRIBUTE PHARMACEUTICALS CANADA, INC.
Reel/Frame 037674/0301 →
Change of Name Mar 7, 2018
From: TRIBUTE PHARMACEUTICALS CANADA INC.
To: ARALEZ PHARMACEUTICALS CANADA INC.
Reel/Frame 045518/0563 →
Security Interest Dec 31, 2018
From: NUVO PHARMACEUTICALS INC.; NUVO PHARMACEUTICALS (IRELAND) DESIGNATED ACTIVITY COMPANY; ARALEZ PHARMACEUTICALS CANADA INC.
To: DEERFIELD PRIVATE DESIGN FUND III, L.P., AS AGENT
Reel/Frame 047875/0410 →
Release of Security Interest Mar 14, 2023
From: DEERFIELD PRIVATE DESIGN FUND III, L.P., AS AGENT
To: NUVO PHARMACEUTICALS INC.; ARALEZ PHARMACEUTICALS CANADA INC.; NUVO PHARMACEUTICALS (IRELAND) DESIGNATED ACTIVITY COMPANY (F/K/A NUVO PHARMACEUTICALS (IRELAND) LIMITED)
Reel/Frame 062974/0236 →